2017
DOI: 10.1038/s41598-017-10013-w
|View full text |Cite
|
Sign up to set email alerts
|

Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma

Abstract: Ape1 is the major apurinic/apyrimidinic (AP) endonuclease activity in mammalian cells, and a key factor in base-excision repair of DNA. High expression or aberrant subcellular distribution of Ape1 has been detected in many cancer types, correlated with drug response, tumor prognosis, or patient survival. Here we present evidence that Ape1 facilitates BRCA1-mediated homologous recombination repair (HR), while counteracting error-prone non-homologous end joining of DNA double-strand breaks. Furthermore, Ape1, co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 42 publications
1
19
0
Order By: Relevance
“…These data suggest that besides important roles in BER, AP nucleases also regulate HR in MM. These data are consistent with the observations in glioblastoma indicating the role of APEX1 in the regulation of HR 59 . However, our study further demonstrates that ability of both APEX1 and APEX2 to regulate HR can be partly attributed to their ability to regulate RAD51 expression in MM cells.…”
Section: Discussionsupporting
confidence: 93%
“…These data suggest that besides important roles in BER, AP nucleases also regulate HR in MM. These data are consistent with the observations in glioblastoma indicating the role of APEX1 in the regulation of HR 59 . However, our study further demonstrates that ability of both APEX1 and APEX2 to regulate HR can be partly attributed to their ability to regulate RAD51 expression in MM cells.…”
Section: Discussionsupporting
confidence: 93%
“…Oxidation of DNA repair proteins by RONS can act as a specific regulatory mechanism of protein structure and function (activation vs inhibition) [66,67]. Oxidative modification can also act to select a DNA repair pathway [5,68,69].…”
Section: Introductionmentioning
confidence: 99%
“…DNA repair is associated with anticancer drug resistance, counteractant of radiotherapy, tumor aggressiveness, and poor prognosis, and inhibition of APE1 is thus a promising strategy for developing antitumor drugs [1][2][3] . Currently, several inhibitors that repress the nuclease activity of APE1 are under evaluation in different phases of clinical trials [1][2][3][4][5][6] . APE1 exerts its function in DNA repair through the nuclease domain which possesses both the endonuclease and the 3′-5′ exonuclease activity 7,8 .…”
mentioning
confidence: 99%